prTGF-beta gene therapy (Vical)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameprTGF-beta gene therapy (Vical)
Drug Alias Namenaked DNA (prTGF-beta) (Vical)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionTransforming growth factor beta receptors agonists
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsRejection of organ transplantationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFresh Tracks Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFresh Tracks Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A